Clinical Trial: A Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Double-blind, Placebo-controlled, Crossover Study, Followed by Open-label Study of KPS-0373 in Patients With SCD
Brief Summary: To evaluate the efficacy and safety of KPS-0373 in patients with SCD.
Detailed Summary:
Sponsor: Kissei Pharmaceutical Co., Ltd.
Current Primary Outcome:
- Scale for Assessment and Rating of Ataxia (SARA) [ Time Frame: 4 weeks + 12 weeks ]
- Upper and lower extremity function [ Time Frame: 4 weeks + 12 weeks ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Kissei Pharmaceutical Co., Ltd.
Dates:
Date Received: October 27, 2009
Date Started:
Date Completion:
Last Updated: September 27, 2010
Last Verified: September 2010